Cargando…
Drug Combinations in Breast Cancer Therapy
Breast cancer therapy involves a multidisciplinary approach com-prising surgery, radiotherapy, neoadjuvant and adjuvant therapy. Effective therapy of breast cancer requires maximum therapeutic efficacy, with mini-mal undesirable effects to ensure a good quality of life for patients. The carefully se...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691849/ https://www.ncbi.nlm.nih.gov/pubmed/30666921 http://dx.doi.org/10.2174/2211738507666190122111224 |
_version_ | 1783443461711593472 |
---|---|
author | Fisusi, Funmilola A. Akala, Emmanuel O. |
author_facet | Fisusi, Funmilola A. Akala, Emmanuel O. |
author_sort | Fisusi, Funmilola A. |
collection | PubMed |
description | Breast cancer therapy involves a multidisciplinary approach com-prising surgery, radiotherapy, neoadjuvant and adjuvant therapy. Effective therapy of breast cancer requires maximum therapeutic efficacy, with mini-mal undesirable effects to ensure a good quality of life for patients. The carefully selected combination of therapeutic interventions provides patients with the opportunity to derive maximum benefit from therapy while minimiz-ing or eliminating recurrence, resistance and toxic effects, as well as ensuring that patients have a good quality of life. This review discusses therapeutic op-tions for breast cancer treatments and various combinations that had been previously exploited. The review will also give an insight into the potential application of the nanotechnology platform for co-delivery of therapeutics in breast cancer therapy. |
format | Online Article Text |
id | pubmed-6691849 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Bentham Science Publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-66918492019-09-05 Drug Combinations in Breast Cancer Therapy Fisusi, Funmilola A. Akala, Emmanuel O. Pharm Nanotechnol Article Breast cancer therapy involves a multidisciplinary approach com-prising surgery, radiotherapy, neoadjuvant and adjuvant therapy. Effective therapy of breast cancer requires maximum therapeutic efficacy, with mini-mal undesirable effects to ensure a good quality of life for patients. The carefully selected combination of therapeutic interventions provides patients with the opportunity to derive maximum benefit from therapy while minimiz-ing or eliminating recurrence, resistance and toxic effects, as well as ensuring that patients have a good quality of life. This review discusses therapeutic op-tions for breast cancer treatments and various combinations that had been previously exploited. The review will also give an insight into the potential application of the nanotechnology platform for co-delivery of therapeutics in breast cancer therapy. Bentham Science Publishers 2019-09 2019-09 /pmc/articles/PMC6691849/ /pubmed/30666921 http://dx.doi.org/10.2174/2211738507666190122111224 Text en © 2019 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/legalcode This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
spellingShingle | Article Fisusi, Funmilola A. Akala, Emmanuel O. Drug Combinations in Breast Cancer Therapy |
title | Drug Combinations in Breast Cancer Therapy |
title_full | Drug Combinations in Breast Cancer Therapy |
title_fullStr | Drug Combinations in Breast Cancer Therapy |
title_full_unstemmed | Drug Combinations in Breast Cancer Therapy |
title_short | Drug Combinations in Breast Cancer Therapy |
title_sort | drug combinations in breast cancer therapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691849/ https://www.ncbi.nlm.nih.gov/pubmed/30666921 http://dx.doi.org/10.2174/2211738507666190122111224 |
work_keys_str_mv | AT fisusifunmilolaa drugcombinationsinbreastcancertherapy AT akalaemmanuelo drugcombinationsinbreastcancertherapy |